Back to results
US 7,094,930 B2Granted
Pharmaceutically acceptable salts of sertraline and pharmaceutical compositions thereof
AssigneePfizer Inc.
InventorsGeorge J. Quallich, Lewin T. Wint
Life of this patent
Estimating the term…
Abstract
The present invention is directed to certain pharmaceutically acceptable salts of the therapeutically potent selective serotonin reuptake inhibitor, sertraline: and pharmaceutical compositions thereof, wherein said salts are selected from the group consisting of the p-toluenesulfonic acid salt, the fumaric acid salt, the benzenesulfonic acid salt, the benzoic acid salt, the L-tartaric acid salt and the (−)-camphor-10-sulfonic acid salt.
Claims20
An acid addition salt of sertraline:
- wherein said salt is selected from the group consisting of the p-toluenesulfonic acid salt, the fumaric acid salt, the benzenesulfonic acid salt, the benzoic acid salt, and the L-tartaric acid salt.
Dependencies are inferred from the claim text.